chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine at approximately 1040am. Patient then moved out to the monitoring area where approximately 5 minutes later stated he felt dizzy and proceeded to syncopize.  Weak thready pulse. patient diaphoretic. Patient was transferred to the first aid area and vs obtained and revealed 82/40. He returned to baseline . He was monitored for an additional 30 minutes with no further incidence. He left clinic with wife at side.
Within 36 hours of the vaccine I experienced floaters in my left eye and through the day I started to lose vision. I went to work the next day and I started to get dizzy so I called a HCF and on 4/6/21, I went in and they took pictures of both of my eyes and said I had a bleeding retinal rupture and immediately sent me to a retinal surgeon on 4/8/21 and I got laser surgery on my right eye at a local office on 4/13/21.
This spontaneous report as received from a medical assistant refers to a male patient of unknown age. Medical history and drug allergies/reactions were denied. In September 2013, the patient was vaccinated with PNEUMOVAX 23 lot J005011 exp 04-DEC-2014, 0.5 ml, intramuscular in the right deltoid. Concomitant medication was denied. In September 2013, within 24 to 72 hours after administration, the patient experienced a fever and redness with swelling at right deltoid administration site. Treatment was recommended over the phone was ice and TYLENOL. No lab diagnostics were performed. On an unspecified date, the outcome of fever and redness with swelling at right deltoid administration site was reported as recovered. Additional information has been requested.
Patient admitted to the hospital Continue BiPAP support Continue remdesivir IV Will start the patient on Decadron 6 mg IV daily Will start the patient IV fluid normal saline at 75 mL/hour Will start the patient on budesonide nebulizer breathing treatment Will start the patient on formoterol nebulizer breathing treatment Will continue cefepime IV Will start the patient on Protonix 40 mg p.o. daily 11/7/2022 VACCINE DOSE 4, 4/29/2022 (3), 11/242021 (2), 3/15/2021 (1)
04/14/21 8:00 PM; Pain on right side of head with blood inside of right eye. Drove to emergency room. Had pressure and pain 4 more times while waiting in emergency room. Evaluated in Emergency room. Admitted to hospital 04/15/21. Had testing CAT scans and MRI determined minor stroke or Ischemic stoke. Numbness on Right side involving right cheek, weakness in RH leg and arm, speech is a little slow; during hospital stay and continued after into April 17th. Released from hospital at 6PM on April 16. As of April 17 at 10:30 AM Still having issues, difficulty thinking, headache, numbness and slight pain in head and arm. Right leg is weak. Will call doctor on Monday April 19 to set up appointment.
Minor fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Minor fatigue) and HEADACHE (headache) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced FATIGUE (Minor fatigue) and HEADACHE (headache). At the time of the report, FATIGUE (Minor fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
she had every symptom/ she was wondering what the chances are that she could have COVID-19 again; she had every symptom/ she was wondering what the chances are that she could have COVID-19 again; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 08Mar2021 (Lot number: EN6198) at the age of 39 years as dose 2, single; and administration date Feb2021 (reported as either 11Feb2021 or 12Feb2021) (Lot number: EN5318) as dose 1, single both for COVID-19 immunisation. Relevant medical history included: "COVID-19", start date: Jan2021 (unspecified if ongoing). There were no concomitant medications. The following information was reported: The patient had her second shot of the COVID-19 vaccine on 08Mar2021. She stated that she woke up at 03:00 in the morning (on 09Mar2021) and she had every symptom. She was wondering what the chances are that she could have COVID-19 again, or if these symptoms were all from the shot. She previously had COVID-19 in Jan2021. The events were reported as non-serious by the consumer.  No follow-up attempts are possible. No further information is expected.
Generalized hives. Lasting about 30 minutes when going away. Ranging from 1 inch to 4-5 inches. On eyes, shoulders,  thighs, legs, knees and elbows. Becoming more frequent for 24 hours
Pt states that she has had arm pain since getting this vaccination and that it has made it hard for her to lift her arm over her head.
Pt stated that after the 2nd day, a bump formed at the injection site and he had a little bit of pain. He said this later turned red and pus-filled, which necessitated an antibiotic.
Tested  covid  positive 08Jan; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a female patient (reporters' mom) of an unknown age received BNT162B2 (BNT162B2 formulation: solution for injection, Lot/batch number and expiry date: Unknown) on 04Jan2021 via an unspecified route of administration and second dose (Lot number: Unknown) on 15Feb both as a single dose for covid-19 immunization. Patient was diagnosed with cardiac infusion, fluid on heart, had difficulty breathing and paralysed vocal cords and clarified all was before covid vaccine. Concomitant medications were not reported. Patient tested positive for covid-19 on 08Jan2021. Caller confirmed that patient lives in nursing home and would like to move her from nursing home to assisted living facility. Outcome of the event was unknown.  No follow-up attempts were possible, information about lot/batch number cannot be obtained.
Vaccinated 2/25/03 in Left arm. Had major reaction with take with lymph pain in R and L axillas, 10 days post vaccination. This subsided a few days later. Scab separated at day 19 post vaccination. Pt experienced shooting pains from site before scab separated. About 2-3 weeks post vaccination the pt. noticed significant shorness of breath with stair climbing. Did not seek medical attention because has a history of SOB, however not to this degree. Pt still reports some SOB, though much improved. Has appointment to see MD on August 15. Has 3 cardiac risk factors: elevated blood pressure, elevated cholesterol, and father had heart attack at 50.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in a 20-year-old male subject who was vaccinated with Engerix B for prophylaxis. Previous and/or concurrent vaccination included diphtheria, tetanus, pertussis given on 2 August 2002 and live attenuated MMR given on 2 August 2002. There were no concurrent medications. On 2 August 2002, 4 September 2002, and 5 February 2003 the subject received the first, second, and third doses of Engerix B (unknown). On 7 August 2007, 4 years after vaccination with Engerix B, 5 years after vaccination with Engerix B, the subject experienced not responding to therapy. Approximately four and half years after completion of the Engerix B series, on 07 August 2007 and 16 August 2007, hepatitis B antibody titers were negative. At the time of reporting the outcome of the event was unspecified.
C/E after flu shot: paresthesias, numbness, inability to walk. Onset of Guillain-Barre 1 day after administration of flu shot. Transferred to ICU and IVIG administered for 2 days. Patient improved.
Started itching, redness and large bump formed. Saw school nurse given BENAADRYL 50 mg. (Still hurts 9/16/15).
Patient's upper left arm showed red, blotchy spots on the outer arm near the injection site and then showed a large red spot (3-4 inches in length) on the inner side of the upper left arm below the lymph node area. Patient started noticing pain and swelling the night she received the vaccinations (about 6-8 hours after injections). The arm is warm to the touch.
First it started as a slight cold. I just treated it as a normal cold but it wouldn't get any better. After the second or third week, I called my doctor and did a video appointment. He suggested that I take benzonatate because I was coughing so much and I couldn't sleep because I was coughing. I tried that for a week and the cold wasn't getting any better. I did also go on a trip during this time which may have made it a bit worse. I was exposed to extreme temperatures of cold and warm. The next thing after that, I contacted my doctor again after my trip and asked if I could get anything else that could help with my breathing. He prescribed an ADVENT inhaler and after a week it didn't feel like it was getting any better. By that point, I noticed I was spiking with a low grade fever with 99.1 at home. I called to see if I can do an in-person appointment with the doctor. I went to the clinic and they took my vitals. My temperature came back at 102.1 and they sent me out of the clinic and completed the rest of the appointment in the car. He suggested to get a chest x-ray and a COVID-19 test and flu test. I went home and fell asleep for about 2 hours then woke up at 5:30PM. I read my messages and it was noted that I tested positive for pneumonia. I was told to go to the hospital which is where I am right now. I was prescribed antibiotics and some other medication. I've taken some ibuprofen and TYLENOL in between there and aspirin because they thought I had a heart condition. I had a stress test and nothing was wrong there which is why they are discharging me in a couple of hours.
NAUSEATED, BLACKED OUT, COLD SWEAT. CAME TO FINE WITHIN A FEW SECONDS EPISODE RESOLVED QUICKLY CLIENT MONITORED FOR 30 MINUTES AND LEFT WITHOUT FURTHER INCIDENT.
Patient called after receiving PNEUMOVAX 23 vaccine. Her arm had swollen from the elbow up and was very hot to the touch. It was also itchy.
Patient called today stating she is experiencing a swollen, aching, muscle in the arm she received the vaccination in. She states the 1st few days arm was stiff, but seems to be more swollen and aching each day. She has numbness and tingling that sometimes migrates down the arm and into her hand. She is going to try to ice and or heat to see any relief occurs, she has tried TYLENOL and it has not helped. She will make an appointment with her primary care physician this week if the pain continues.
Allergic to vaccine; Initial information was received on 08-Feb-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional (patient).  This case involves a patient (unknown demographics) who was allergic to vaccine (allergy to vaccine), while he/she received INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (batch number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was allergic to vaccine (allergy to vaccine) (unknown latency) following the administration of INFLUENZA VACCINE. The event was non-serious.  It was unknown if the patient experienced any additional symptoms/events.   The details of medication and reason for taking the medicine were not provided.  There were no lab data/results available.   At the time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
Cold.; Clammy; Feeling like fever/ but no measurable fever; This is a spontaneous report from a contactable consumer, the parent. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergy to lots of foods. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included allergy shots (as reported) for unknown indication from an unknown start date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021, after 21 hours of vaccination, the patient experienced cold, clammy and feeling like fever, but no measurable fever. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not  taken as a result events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events cold, clammy and feeling like fever but no measurable fever was unknown at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The patient was in her  watch period after the first dose, she fainted maybe 7 minutes later, when the pharmacist approached the patient  had already awoken. She then said she felt like she was going to throw up. She was given water and a trash can, and threw up in the trash. We called the ambulance but the father refused, and told him we needed to monitor another 15 minutes. The father waited with the daughter and left after 15 minutes.
The patient started with right eye pain at onset of adverse event. The next morning the pain had worsened along with a new adverse effect of eye drooping in the same eye (right). She also had decreased visual acuity and erythema around the eye. The patient saw her opthalmologist who thinks it is related to the Zostavax injection. Treatment with Systane Ultra.
PT lives at at nursing home; pt had a positive COVID test on 11/23/21 in the nursing home; placed in isolation; DNR; comfort measures; pt passed away in the nursing home.
My daughter came down with a fever for 5 days starting on Feb 19 which was 6 days after her MMR and Varicella vaccines.  According to multiple sources online her reaction was consistent to a reaction to the Measles portion of the vaccine.  She did have a minor rash. She continued with fever and not wanting to eat anything and her illness and fever progressed from there to a possible diagnosis of Mono about a week later which was based on a monospot test which according to the CDC is not very reliable in children and her Epstein Barr results were not returned or shipped to facility because of inclement weather (that's where they send bloodwork for Epstein Barr.) She got worse after the "diagnosis". She developed a terrible crust over her eyes that kept coming throughout the day for over about a week and her nose was terribly full of snot.  She was not eating still and I was having to give her Ensure everyday along with her fluids for 7 weeks to keep her "fed."  Her white count at the time of the Mono diagnosis was 23,000.  She was still not eating on her own much by the first week in April (only a bite here and there) I was continuing to talk with nurse periodically about her condition on the phone and I was continuing to keep her hydrated and give her Ensure at home. On April 9th she came down with 104 fever and we tried to treat her at home for a couple of days but there was no change so on April 11 we took her to the ER and I spent 5 hours there with her as they ran tests for everything imaginable.  Her white count was still very high (22,000) and according to the ER doc nothing was showing us the cause of the fever but he decided to treat her symptom (fever) as a bacterial infection. Later on her doctor told me that the xray report showed a tiny sign of something that could have been early Pneumonia.  I have obtained copies of most of her records related to this situation.  Nothing ever cultured out bacterially speaking but the antibiotic that she was given has seemed to help and so far as of April 20th she has been better.  This has been a Very difficult time for our family as we have tried to figure out what could be wrong with our child.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 28-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications were not reported. The treatment information was not provided.
Narrative:  70yo male patient died on 9/8/21 at Hospital (non-agency hospital). Pt with the following medical history: PAST MEDICAL ischemic colitis contributing to hypotension and syncope CAD s/p 4v CABG on Aug 28/2011, PCI in 1995 ICM (last EF of 35% in Aug 2011, 52% on last TTE) PAF HTN PTSD h/o Hep C (txd) GERD # ED. #BL cerumen parital impaction w/ itching and irritation. # RIGHT lower leg dermatitis. PAST SURGICAL Left eye blindness 2/2 shrapnel Right low leg 2/2 osteomyelitis Right palmar hand Pt had covid vaccines on 2/23/21 & 3/16/2021. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Vomiting 08/10, headaches started 08/11, landed in the ER 08/13 at around 12:30am, treated and released for headaches and nausea. By Sat 08/14 around 9pm we are back at the ER for the headaches, vomiting and now rapid heart beat (in the 150's). During these days ibuprofen and acetaminophen weren't working. She did take Zofran for the nausea on 08/11 and 08/13. Hospital gave her fluids and meds through the IV that helped everything except rapid heart beat.
Developed aching, fever, nausea, abd. pain, dizziness, decreased appetite, excessive sweating within 1 st 12 hrs. after vaccine. Next am., P.E. WNL. Reevaluated after 48 hrs, pt. asymptomatic. P/E normal
After the first dose:  Diarrhea Muscle pain in the left arm, not the injection site Legs weak Left arm felt weak and not as in control, some tingling Light Headedness/Not in control
This spontaneous report has been received from a pharmacist, concerning a 1 year old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 15-JUN-2017, the patient was vaccinated with properly stored, but expired dose of M-M-R II lot # L015279 and expiration date of 30-APR-2017 (dose and route of administration were not provided) for prophylaxis. Concomitant therapies included sterile diluent used for reconstitition (lot # and expiration date of the sterile diluent were not provided). No adverse effects were reported. Additional information has been requested.
Numbness and tingling in lower arms and hands bilaterally and in face.  Heaviness in chest (without tightness or wheezing).  Both occurred within minutes of receiving vaccine.  Extreme fatigue occurred later in the evening.  All symptoms were gone by the next morning.
This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 64-year-old female patient who received SHINGRIX (batch number MY2B2, expiry date 28th February 2021) for prophylaxis. On 31st August 2018, the patient received SHINGRIX. On 31st August 2018, unknown after receiving SHINGRIX, the patient experienced wrong solution used in drug reconstitution and inappropriate preparation of medication. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate preparation of medication were unknown. Additional details were provided as follows: The healthcare professional reconstituted SHINGRIX with sterile water instead of the adjuvant provided with the vaccine and administered it to the patient, which led to wrong solution used in drug reconstitution and inappropriate preparation of medication.
Received H1N1 vaccine 11/11/2009 14:00 (end of shift). She went home and by 10:10 symptoms started. She is in ER now 11/12/2009-14:00 with swelling to right side (injection given to right deltoid) including face, arm, hand and leg. With burning sensation from neck to right shoulder and numbness to right arm and leg from the knee up.
MMR live attenuated vaccine was administered to a patient who has HIV positive without consultation with provider. However, later found that patient's CD4 cell count was 598 on January 2010 per patient.
Pneumonia; A spontaneous report was received from a physician concerning a 78 years-old, male patient, who received Moderna's COVID-19 Vaccine and who experienced pneumonia.  The patient's medical history included chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Products known to have been used by the patient, within two weeks prior to the event, included umeclidinium bromide/ vilanterol trifenatate, irbesartan, amlodipine besilate, metoprolol, glipizide, metformin, omeprazole, magnesium, and omega 3.  The patient received their first of two planned doses of mRNA-1273 intramuscularly on 22 Jan 2021 for the prophylaxis of COVID-19 infection.   On 22 Jan 2021 within a few hours of first dose, the patient developed fever, chills, weakness, and productive cough. On 24 Jan 2021, the patient was admitted to hospital due to oxygen levels in the 60s with productive cough, yellow sputum, and short of breath. He was diagnosed with pneumonia. During hospitalization, the patient had two negative PCR COVID-19 tests.  Treatment information was not provided.  The second dose of mRNA-1273 was discontinued in response to the events.  The outcome of event pneumonia  was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded. Patient's medical history of COPD and pulmonary fibrosis may have been contributory.
Her back went out; She can't stand, she can't walk because of that; Her back went out; She can't stand, she can't walk because of that; Her back went out; She can't stand, she can't walk because of that; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received her first dose of bnt162b2 (BNT162B2 reported as COVID 19 VACCINE; lot number: EL3249; expiration date: unknown) at unknown age of vaccination via an unspecified route of administration on 22Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that got the first dose of the vaccine last Friday (22Jan2021) and last Saturday (23Jan2021) her back went out. She further reported that means she can't stand, she can't walk because of that. The patient inquired if she can take Prednisone and if she will take Prednisone, would that affect the efficacy of the vaccine. The outcome of the events was unknown.